Native valve right sided infective endocarditis.
Right-sided infective endocarditis (RSIE) accounts for 5-10% of all cases of infective endocarditis (IE), and is predominantly encountered in the injecting drug user (IDU) population, where HIV and HCV coinfections often coexist. Staphylococcus aureus is the most common pathogen. The pathogenesis of RSIE is still not well understood. RSIE usually presents as a persistent fever with respiratory symptoms whilst signs of systemic embolisation as seen in left-sided IE are notably absent. The prompt diagnosis of RSIE thus requires a high index of suspicion. Transthoracic echocardiography (TTE) can detect the majority of RSIE, whilst transoesophageal echocardiography (TOE) can increase sensitivity. Virulence of the causative organism and vegetation size are the major determinants of prognosis. Most cases of RSIE resolve with appropriate antibiotic administration.
['Akinosoglou|Karolina|K|', 'Apostolakis|Efstratios|E|', 'Marangos|Markos|M|', 'Pasvol|Geoffrey|G|']
D000900:Anti-Bacterial Agents D060085:Coinfection D004452:Echocardiography D004697:Endocarditis, Bacterial D015658:HIV Infections D006349:Heart Valve Diseases D019698:Hepatitis C, Chronic D006801:Humans D011379:Prognosis D011664:Pulmonary Valve D012307:Risk Factors D013203:Staphylococcal Infections D013211:Staphylococcus aureus D015819:Substance Abuse, Intravenous D014261:Tricuspid Valve
Endocarditis and HIV Endocarditis in IDU Pneumonic valve endocarditis Right sided endocarditis Tricuspid native valve endocarditis